New Europe's promise for life sciences

Sergey Filippov & Kálmán Kalotay


The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector perceiving it as a basis for long-term development. Whilst the R&D activities of global multinationals in life sciences still remain concentrated in the Triadic economies, these companies increasingly seek for new location to tap the knowledge. New EU member states emerge as such prospective locations. Notwithstanding the interest towards this sector, the body of literature on the development of life sciences in new EU member states, and particularly, the role of multinational companies, remains scant. In this explorative study we attempt to fill this gap and focus on the role of multinational companies in the Czech life sciences sector.

JEL codes: F21 F23 L65 O32

Keywords: life sciences; biotechnology; pharmaceuticals; multinational companies; EU

UNU-MERIT Working Papers ISSN 1871-9872

Download the working paper